Horizon Discovery Introduces High Throughput Platform for Immuno-Oncology Research
New platform enables researchers to rapidly identify cutting-edge anti-cancer drugs
New platform enables researchers to rapidly identify cutting-edge anti-cancer drugs
Researchers’ use of ParsortixTM System for studies into multiple cancers confirms the cell separation technology’s ability to harvest viable circulating tumor cells for a broad range of downstream analyses
Products reviewed by clinical scientists around the world
Collaboration with Mirati Therapeutics targets MET gene mutations to personalize treatment
In vitro diagnostic approved to support use of Bristol-Myers Squibb’s OPDIVO® for non-squamous non-small cell lung cancer
Latest news from the Clinical Diagnostics community
First truly end-to-end solution for next-generation sequencing receives Red Dot award
Discover SelectScience® video interviews and articles about the latest Alzheimer’s disease research methods
Cutting-edge digital PCR facilitates clinically relevant discovery
New instrument designed to offer a highly automated and flexible solution while maintaining reliable and accurate test performance
Current applications of flow cytometry in the clinical laboratory
Analyzing 50-year old DNA from highly complex samples
The latest reviews written for clinical products in the SelectScience® directory
The new technology speeds up in-database, large-scale analyses by a factor of approximately 400, helping to advance genomic medical research
TATAA Biocenter also to introduce Swift Biosciences’ NGS products in its popular NGS training courses
Shimadzu’s new protein sequencers offer enhanced sensitivity and compliance with FDA
Maximizes CRISPR gene editing efficiency and lowers the risk of off-target effects
DeNovix Inc. launches the Ultra High Sensitivity dsDNA fluorescence quantification assay